CancerDrs

Cervical Cancer clinical trials in West Virginia

6 actively recruiting cervical cancer trials at 7 sites across West Virginia.

Data from ClinicalTrials.gov · last refreshed

Phase 3 Recruiting NIH

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

This phase III trial compares the addition of induction chemotherapy, with carboplatin, paclitaxel and pembrolizumab, to chemotherapy and radiation, with cisplatin and pembrolizumab followed by pembrolizumab maintenance for the treatment o…

Sponsor: National Cancer Institute (NCI)
NCT ID: NCT07061977
Sites in West Virginia:
  • United Hospital Center — Bridgeport, West Virginia
  • West Virginia University Charleston Division — Charleston, West Virginia
  • West Virginia University Healthcare — Morgantown, West Virginia
  • Camden Clark Medical Center — Parkersburg, West Virginia
Phase 3 Recruiting Academic/Other

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

This phase III trial tests if gabapentin can prevent the need for opiate pain medication for mouth sores (oral mucositis) in patients undergoing treatment with chemotherapy and radiation for squamous cell carcinoma of the head and neck reg…

Sponsor: Alliance for Clinical Trials in Oncology
NCT ID: NCT06992427
Sites in West Virginia:
  • United Hospital Center — Bridgeport, West Virginia
  • WVUH-Berkely Medical Center — Martinsburg, West Virginia
  • West Virginia University Healthcare — Morgantown, West Virginia
  • Camden Clark Medical Center — Parkersburg, West Virginia
  • Princeton Community Hospital — Princeton, West Virginia
Phase 3 Recruiting NIH

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

This phase III trial compares the effect of adding cetuximab to pembrolizumab versus pembrolizumab alone in treating patients with head and neck squamous cell carcinoma (HNSCC) that has come back after a period of improvement (recurrent) a…

Sponsor: National Cancer Institute (NCI)
NCT ID: NCT06589804
Sites in West Virginia:
  • West Virginia University Charleston Division — Charleston, West Virginia
Phase 3 Recruiting Industry

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

The purpose of this study is to evaluate the efficacy and safety of sonesitatug vedotin in combination with capecitabine with or without rilvegostomig in first-line (1L) Claudin18.2 (CLDN18.2)-positive, human epidermal growth factor recept…

Sponsor: AstraZeneca
NCT ID: NCT07431281
Sites in West Virginia:
  • Research Site — Charleston, West Virginia
NA Recruiting Network

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

This is a randomized controlled trial to compare survival for patients who undergoe robotic assisted laparoscopy versus open hysterectomy and lymph node assessment for the treatment of early stage cervical cancer.

Sponsor: GOG Foundation
NCT ID: NCT04831580
Sites in West Virginia:
  • West Virginia University — Morgantown, West Virginia
  • West Virginia — Morgantown, West Virginia
NA Recruiting NIH

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)

This clinical trial evaluates the use of self-collected vaginal samples for human papillomavirus (HPV) testing in patients referred for a colposcopy and/or cervical excisional procedures to improve cervical cancer prevention. HPV is a comm…

Sponsor: National Cancer Institute (NCI)
NCT ID: NCT07281430
Sites in West Virginia:
  • West Virginia University Healthcare — Morgantown, West Virginia

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-10-01